Business Description
SMS Pharmaceuticals Ltd
ISIN : INE812G01025
Compare
Compare
Traded in other countries / regions
532815.India IPO Date
2007-02-28Description
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the manufacturing and sale of active pharmaceutical ingredients (API's), and their intermediates viz. Metal Acetylacetonates, Diltiazem Hydrochloride and Taxol C-13 Side Chain. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, among others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.51 | |||||
| Debt-to-EBITDA | 2.15 | |||||
| Interest Coverage | 4.74 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.31 | |||||
| Beneish M-Score | -2.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8 | |||||
| 3-Year EBITDA Growth Rate | -0.9 | |||||
| 3-Year EPS without NRI Growth Rate | -7.3 | |||||
| 3-Year FCF Growth Rate | 67.9 | |||||
| 3-Year Book Growth Rate | 9.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.51 | |||||
| 9-Day RSI | 39.41 | |||||
| 14-Day RSI | 37.59 | |||||
| 6-1 Month Momentum % | 35.86 | |||||
| 12-1 Month Momentum % | 127.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | |||||
| Quick Ratio | 0.71 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 187.18 | |||||
| Days Sales Outstanding | 95.98 | |||||
| Days Payable | 119.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.15 | |||||
| Dividend Payout Ratio | 0.06 | |||||
| Forward Dividend Yield % | 0.15 | |||||
| 5-Year Yield-on-Cost % | 0.15 | |||||
| Shareholder Yield % | -0.71 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.84 | |||||
| Operating Margin % | 12.38 | |||||
| Net Margin % | 7.75 | |||||
| FCF Margin % | -0.27 | |||||
| ROE % | 11.27 | |||||
| ROA % | 5.66 | |||||
| ROIC % | 8.35 | |||||
| ROC (Joel Greenblatt) % | 12.6 | |||||
| ROCE % | 14.25 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.21 | |||||
| PE Ratio without NRI | 36.23 | |||||
| Shiller PE Ratio | 34.38 | |||||
| PEG Ratio | 90.58 | |||||
| PS Ratio | 2.81 | |||||
| PB Ratio | 3.83 | |||||
| Price-to-Tangible-Book | 3.84 | |||||
| Price-to-Operating-Cash-Flow | 43 | |||||
| EV-to-EBIT | 24.28 | |||||
| EV-to-EBITDA | 18.27 | |||||
| EV-to-Revenue | 3.17 | |||||
| EV-to-FCF | -1127.1 | |||||
| Price-to-Projected-FCF | 5.34 | |||||
| Price-to-Median-PS-Value | 1.74 | |||||
| Price-to-Graham-Number | 2.49 | |||||
| Price-to-Net-Current-Asset-Value | 200.47 | |||||
| Earnings Yield (Greenblatt) % | 4.12 | |||||
| FCF Yield % | -0.09 | |||||
| Forward Rate of Return (Yacktman) % | 0.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SMS Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,656.728 | ||
| EPS (TTM) (₹) | 7.03 | ||
| Beta | 1.54 | ||
| Volatility % | 47.13 | ||
| 14-Day RSI | 37.59 | ||
| 14-Day ATR (₹) | 15.279919 | ||
| 20-Day SMA (₹) | 275.8025 | ||
| 12-1 Month Momentum % | 127.97 | ||
| 52-Week Range (₹) | 114.2 - 398 | ||
| Shares Outstanding (Mil) | 84.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SMS Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SMS Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
SMS Pharmaceuticals Ltd Frequently Asked Questions
What is SMS Pharmaceuticals Ltd(BOM:532815)'s stock price today?
The current price of BOM:532815 is ₹254.60. The 52 week high of BOM:532815 is ₹398.00 and 52 week low is ₹114.20.
When is next earnings date of SMS Pharmaceuticals Ltd(BOM:532815)?
The next earnings date of SMS Pharmaceuticals Ltd(BOM:532815) is .
Does SMS Pharmaceuticals Ltd(BOM:532815) pay dividends? If so, how much?
The Dividend Yield %  of SMS Pharmaceuticals Ltd(BOM:532815) is 0.15% (As of Today), Highest Dividend Payout Ratio of SMS Pharmaceuticals Ltd(BOM:532815) was 0.13. The lowest was 0.04. And the median was 0.05. The  Forward Dividend Yield % of SMS Pharmaceuticals Ltd(BOM:532815) is 0.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers